IASLC Statement on Lung Cancer Screening with Low-Dose Computed Tomography

(1)

Position Statement | English

Create Account

Availability

On-Demand

Cost

$0.00

Credit Offered

No Credit Offered

The IASLC recognizes the importance of lung cancer screening with low-dose computed tomography (LDCT) in high risk individuals to significantly reduce lung cancer mortality.

Read the 2018 IASCL Position Statement on implementing screening programs that incorporate a multidisciplinary group of experts and use best practice in screening care.